Overview
ABSTRACT
The médical industry is one of the main beneficiaries of NewSpace or commercial space sector evolution. Experimentation in microgravity may solve scientific challenges in medical or life sciences fields such as diagnosis, pharmacy, drug research, biotechnology and medicine in general. This paper article is an overview of the benefits provided by microgravity to better understand genes and metabolism, to increase growth of certain cell lines, and to facilitate the growth of high-quality microstructures or crystals.
Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.
Read the articleAUTHOR
-
Pascale LEFEBURE: Biotechnology Engineer, Aerospace project manager - SIGMA-VISION.COM (Targasonne, France)
INTRODUCTION
Be it in the managerial, commercial or technological field, innovation drives business. Of course, you need to have a vision, a nose for current trends, but you must also have the capacity to put that innovation into action. Every day, space agencies worldwide enable creative experiments in space to take wing, for a wide range of clients.
Efforts made to conquer space have generated innumerable patents and inspired the development of whole new product categories. Between 2001 and 2021, the Center for the Advancement of Science in Space (CASIS) supported the sending of more than 500 payloads to the American national laboratory on the International Space Station (ISS) , 70% of which arose from the private sector, including projects from companies on the Fortune 500 list, innovative start-ups and large organisations.
Microgravity experimentation overcomes scientific challenges in many fields of life sciences or the medical sector, such as diagnosis, pharmacy, the discovery of new drugs, biotechnology and medicine in general. This new generation of space activities is contributing to NewSpace , the development of the commercial space sector offering a range of possibilities ranging from the design of more effective treatments to the development of new plant varieties better suited to extreme conditions. Microgravity offers a range of possibilities leading not just to new pro-ducts, but to entirely new categories which can fundamentally change the way we live.
In this article we present the benefits of microgravity research for medicine and life sciences.
Field : Space research
Degree of technology dessemination : Maturity
Technologies involved : Space station, launchers, satellites, payloads, bioreactor
Applications : Medicine, life sciences, chemistry, cosmetics
Main French actors :
Competitiveness clusters: Aerospace Valley
National centres: French National Centre for Space Studies (CNES)
Industries: Novespace, Sanofi
Other actors in the world : Center for the Advancement of Science in Space (CASIS), European Space Agency (ESA), National Aeronautics and Space Administration (NASA), Tympanogen LLC, Angiex Inc, Space X, LambdaVision
...
The Ultimate Scientific and Technical Reference
KEYWORDS
International Space Station ISS | microgravity | Space laboratories | incubator | medical industry
This article is included in
Aerospace systems
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
New Space: improved understanding of living beings through microgravity
An unrivalled laboratory
Bibliographical sources
Sources bibliographiques
Standards
European Cooperation for Space Standardization ECSS guidelines
Directory
Manufacturers – Suppliers – Distributors (partial list)
Center for the Advancement of Science Space (CASIS) https://www.issnationallab.org
Tympanogen LLC http://www.tympanogen.com
The Ultimate Scientific and Technical Reference
